Abstract
THE human T-lymphotropic virus type I (HTLV-I), the first human retrovirus to be characterized, is associated with adult T-cell leukaemia and a chronic progressive disease of the central nervous system termed tropical spastic paraparesis, or HTLV-I-associated myelopathy1–4. Only 1% of individuals infected with HTLV-I develop clinical disease however5. The various manifestations of an HTLV-I infection may be related to differences in the genetic backgrounds of individuals6, infection with variant strains of HTLV-I (ref. 7), differences in viral tropism8 or host immune response to the virus. Whereas the humoral response to HTLV-I is well characterized3,4,9,10 little is known about the human cellular immune response, such as the production of cytotoxic T lymphocytes11–13. Here we report the presence of high levels of circulating HTLV-I-specific cytotoxic T lymphocytes in patients with HTLV-I associated neurological disease but not in HTLV-I seropositive individuals without neurological involvement. These cytotoxic T lymphocytes are CD8+, HLA class I- restricted and predominantly recognize the HTLV-I gene products encoded in the regulatory region pX. These findings suggest that HTLV-I-specific cytotoxic T lymphocytes may contribute to the pathogenesis of associated neurological disorders associated with HTLV-I.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Poeisz, B. J. et al. Proc natn. Acad. Sci. U.S.A. 77, 7415–7419 (1980).
Wong-Staal, F. & Gallo, R. C. Nature 317, 395–413 (1985).
Gessain, A. et al. Lancet ii, 407–410 (1985).
Osame, M. et al. Lancet i, 1031–1032 (1986).
Murphy, E. L. et al. Int. J. Cancer 43, 250–253 (1989).
Usuku, K. et al. Ann. Neurol. (Suppl.) 23, S143–S150 (1988).
Jacobson, S., Raine, C. S., Mingioli, E. S. & McFarlin, D. E. Nature 331, 540–542 (1988).
Moore, W. G. R., Traugott, U., Schienberg, L. C. & Raine, C. S. Neurology 26, 523–530 (1989).
Palker, T. J. et al. J. Immun. 142, 971–978 (1989).
Kurata, A. et al. J. Immun. 143, 2024–2030 (1989).
Kannagi, M. K. et al. J. Immun. 130, 2942–2946 (1983).
Mitsuya, H. L. et al. J. exp. Med. 158, 994–999 (1983).
Jacobson, S., Gupta, A., Mattson, D., Mingioli, E. S. & McFarlin, D. E. Ann. Neurol. 27, 149–155 (1990).
Shida, H. et al. EMBO J. 6, 3379–3384 (1987).
Nam, S. H. Kidokoro, M., Shida, H. & Hatanaka, M. J. Virol. 62, 3718–3728 (1988).
Siomi, H. et al. Cell 55, 197–209 (1988).
Tanaka, Y., Tozzawa, H., Koyanagi, Y. & Shida, H. J. Immun. 144, 4202–4211 (1990).
Townsend, A. & Bodmer, H. A. Rev. Immun. 7, 601–624 (1989).
Shimojo, N. et al. Intern. Immun. 2, 193–200 (1990).
Plata, F. et al. Immunodeficiency Rev. 1, 227–246 (1989).
Fleischer, B. & Kreth, H. W. Hum. Immun. 7, 239–248 (1983).
Waldmann, T. A. et al. J. clin. Invest. 73, 1711–1718 (1983).
Gessain, A. et al. Blood 75, 428–433 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jacobson, S., Shida, H., McFarlin, D. et al. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348, 245–248 (1990). https://doi.org/10.1038/348245a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/348245a0
This article is cited by
-
The HTLV-1 proviral status is a potential prognostic biomarker for adult T-cell leukemia-lymphoma treated with allogeneic stem cell transplantation
Bone Marrow Transplantation (2021)
-
Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia/lymphoma
Modern Pathology (2021)
-
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities
Current Oncology Reports (2021)
-
HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina
Retrovirology (2020)
-
Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis
Journal of NeuroVirology (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.